Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT

Gallbladder cancer (GBC) is characterized by poor prognosis, early metastasis, and high recurrence rates, which seriously threaten human health. The effect of lenvatinib, a widely used drug in anti-hepatocellular carcinoma in China, on GBC progress, as well as its underlying molecular mechanism, rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Jianwen, Qi, Lei, Liang, Jialu, Zong, Ke, Liu, Wentao, Li, Renfeng, Feng, Ruo, Zhai, Wenlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120192/
https://www.ncbi.nlm.nih.gov/pubmed/33995632
http://dx.doi.org/10.7150/jca.50292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120192/
https://www.ncbi.nlm.nih.gov/pubmed/33995632
http://dx.doi.org/10.7150/jca.50292

Ejemplares similares